biotech Archives - Boston Life Sciences Times

NEJM Publishes Data Suggesting Zorevunersen May Modify Disease Course in Dravet Syndrome

March 5, 2026

Arsenal Medical Treats First Patient with ResQFoam Device for Life-Threatening Abdominal Bleeding

March 4, 2026

Konovo Appoints Jessica Santos as Chief Compliance and Privacy Officer

March 3, 2026

THIS WEEK'S STORIES

Amylyx Pharmaceuticals Narrows Losses in 2025 as Phase 3 Avexitide Trial Nears Completion

March 3, 2026

Surescripts Reports Record Growth in Interoperability and Faster Prescription Access in 2025

March 3, 2026

Cognito Therapeutics Raises $105 Million Series C to Advance Alzheimer’s Therapy Platform

March 5, 2026

ABOUT US

Life Science Times is New England’s premier life sciences publication, covering the Pharma, Biotech, MedTech and Public Health sectors nationwide with a special focus on New England. Updated daily, we cover the latest news in everything else that touches any rubric of the rapidly growing life sciences industry.

Tag: biotech

Most Read

Response Pharmaceuticals Reports Positive Phase 2 Data for RDX-002 in Post-GLP-1 Weight Management

Proxima Appoints Three Scientists to Advisory Board to Advance Proximity Therapeutics Platform

Harrison.ai Receives FDA Clearance for AI Tool to Triage Acute Infarcts on Non-Contrast CT Brain Scans

NEJM Publishes Data Suggesting Zorevunersen May Modify Disease Course in Dravet Syndrome

EDITOR PICKS

NEJM Publishes Data Suggesting Zorevunersen May Modify Disease Course in Dravet Syndrome

Arsenal Medical Treats First Patient with ResQFoam Device for Life-Threatening Abdominal Bleeding

Konovo Appoints Jessica Santos as Chief Compliance and Privacy Officer

THIS WEEK'S STORIES

Amylyx Pharmaceuticals Narrows Losses in 2025 as Phase 3 Avexitide Trial Nears Completion

Surescripts Reports Record Growth in Interoperability and Faster Prescription Access in 2025

Cognito Therapeutics Raises $105 Million Series C to Advance Alzheimer’s Therapy Platform

POPULAR CATEGORY

ABOUT US

FOLLOW US